Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct 1;44(10):760-763.
doi: 10.1097/DAD.0000000000002263. Epub 2022 Jul 19.

Cutaneous Ossifying Amyloidoma

Affiliations
Case Reports

Cutaneous Ossifying Amyloidoma

Celia Requena et al. Am J Dermatopathol. .

Abstract

Amyloidoma, otherwise known as tumoral amyloidosis, is a localized deposition of amyloid (AL-type or AA type) without systemic amyloidosis. It is the rarest form of tissue amyloid deposition, and up to 7% of amyloidomas develop systemic amyloidosis.Cutaneous AL-type amyloidoma is considered by many authors as an unusual variant of primary cutaneous marginal zone lymphoma. Although cutaneous amyloidoma can form calcifications, ossification is extremely unusual, with only 1 case previously published to date.We report the case of a 75-year-old woman with voluminous and strikingly ossifying AL-type amyloidoma in the left pretibial skin. Her medical history included excision of hepatic hydatidic cysts 25 years prior and diffuse large B-cell lymphoma of the left parotid gland 8 years prior treated with chemotherapy and radiotherapy with complete response. After the diagnosis of amyloidoma, an extension study with cervical, chest, abdominal, and pelvic TC was performed, with no additional lesions found. Serum and protein electrophoresis revealed elevations in kappa light chain and IgA immunoglobulin levels but did not reveal monoclonal bands. In situ hybridization for immunoglobulin light chains showed monotypic kappa expression in plasma cells infiltrating the amyloidoma.Extensive ossification in amyloidomas can make diagnosis difficult; therefore, we describe an interesting case of this histopathologically peculiar amyloidoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Merlini G, Belloti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596.
    1. Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and Therapy: a systematic review. JAMA. 2020;324:79–89.
    1. Pasternak S, Wright BA, Walsh N. Soft tissue amyloidoma of the extremities: report of a case and review of the literature. Am J Dermatopathol. 2007;29:152–155.
    1. Moon AO, Calamia KT, Walsh JS. Nodular amyloidosis: review and long-term follow-up of 16 cases. Arch Dermatol. 2003;139:1157–1159.
    1. Walsh NM, Lano IM, Green P, et al. Amyloidoma of the skin/subcutis. Cutaneous amyloidosis, plasma cell dyscrasia or a manifestation of primary cutaneous marginal zone lymphoma? Am J Surg Pathol. 2017;41:1069–1076.

Publication types